Header cover image

U.S. Pharmaceuticals & Biotech Net Cash Stocks With A Growth Track Record

UPDATED Nov 23, 2022

These companies have grown profits at a double digit rate for 5 years or more. And they have net cash.

5 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
VRTXVertex PharmaceuticalsUS$316.163.5%69.8%US$81.2bUS$323.74PE24.8xE10.0%n/a
MRNAModernaUS$176.81-4.6%-35.3%US$67.9bUS$211.25PE5.8xE-40.1%n/a
ABCLAbCellera BiologicsUS$14.00-3.6%-3.0%US$4.0bUS$29.33PE16.1xE-59.6%n/a
BIOQBioqualUS$78.507.5%-21.5%US$70.2mn/aPE13.3xn/a1.3%
RSCFReflect ScientificUS$0.068-2.0%-64.2%US$5.8mn/aPE11.3xn/an/a
Page 1 of 1